Delivery Order SPE2DB20D1109-SPE2DB23FN16V
Award Date 12/13/22
Potential Completion Date 12/14/22
Potential Value $1.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on August 11, 2021, with a ceiling value of $2,910.20. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication in 180 ml doses to the Defense Logistics Agency (DLA). The contract, valued at $1,270.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract has a completion date of June 20, 2024 and is a firm-fixed price delivery order. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml) to the Defense Logistics Agency (DLA). The $4,600.08 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,441.98 firm fixed price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 15, 2024 with a completion date of May 16, 2024. The contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 180 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a ceiling value of $4,436.80 and a completion date of December 3, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation,...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,032.24 firm fixed-price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication to the Defense Logistics Agency (DLA). The $1,431.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The fixed-price delivery order has a ceiling value of $1,640.44 and a completion date of January 26, 2023. The award was made on January 25, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a key vendor for...